The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
11 Oct 2021
Historique:
received: 16 02 2021
accepted: 15 09 2021
pubmed: 16 9 2021
medline: 16 10 2021
entrez: 15 9 2021
Statut: epublish

Résumé

17α-Hydroxylase/17,20-lyase deficiency (17OHD) caused by mutations in the CYP17A1 gene is a rare form of congenital adrenal hyperplasia typically characterised by cortisol deficiency, mineralocorticoid excess and sex steroid deficiency. To examine the phenotypic spectrum of 17OHD by clinical and biochemical assessment and corresponding in silico and in vitro functional analysis. Case series. We assessed eight patients with 17OHD, including four with extreme 17OHD phenotypes: two siblings presented with failure to thrive in early infancy and two with isolated sex steroid deficiency and normal cortisol reserve. Diagnosis was established by mass spectrometry-based urinary steroid profiling and confirmed by genetic CYP17A1 analysis, revealing homozygous and compound heterozygous sequence variants. We found novel (p.Gly111Val, p.Ala398Glu, p.Ile371Thr) and previously described sequence variants (p.Pro409Leu, p.Arg347His, p.Gly436Arg, p.Phe53/54del, p.Tyr60IlefsLys88X). In vitro functional studies employing an overexpression system in HEK293 cells showed that 17,20-lyase activity was invariably decreased while mutant 17α-hydroxylase activity retained up to 14% of WT activity in the two patients with intact cortisol reserve. A ratio of urinary corticosterone over cortisol metabolites reflective of 17α-hydroxylase activity correlated well with clinical phenotype severity. Our findings illustrate the broad phenotypic spectrum of 17OHD. Isolated sex steroid deficiency with normal stimulated cortisol has not been reported before. Attenuation of 17α-hydroxylase activity is readily detected by urinary steroid profiling and predicts phenotype severity. Here we report, supported by careful phenotyping, genotyping and functional analysis, a prismatic case series of patients with congenital adrenal hyperplasia due to 17α-hydroxylase (CYP17A1) deficiency (17OHD). These range in severity from the abolition of function, presenting in early infancy, and unusually mild with isolated sex steroid deficiency but normal ACTH-stimulated cortisol in adult patients. These findings will guide improved diagnostic detection of CYP17A1 deficiency.

Identifiants

pubmed: 34524979
doi: 10.1530/EJE-21-0152
pii: EJE-21-0152
pmc: PMC8558848
doi:
pii:

Substances chimiques

Gonadal Steroid Hormones 0
Mineralocorticoids 0
Steroids 0
CYP17A1 protein, human EC 1.14.14.19
Steroid 17-alpha-Hydroxylase EC 1.14.14.19
Corticosterone W980KJ009P
Hydrocortisone WI4X0X7BPJ

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-741

Références

J Clin Endocrinol Metab. 2009 Aug;94(8):3058-64
pubmed: 19454579
J Clin Endocrinol Metab. 2011 Nov;96(11):E1798-806
pubmed: 21880796
J Endocr Soc. 2019 Nov 18;4(2):bvz016
pubmed: 32051920
Clin Chem. 2020 Sep 1;66(9):1150-1154
pubmed: 32870997
Am J Med Genet A. 2004 Jul 30;128A(3):223-31
pubmed: 15216541
Nat Genet. 2004 Mar;36(3):228-30
pubmed: 14758361
Arq Bras Endocrinol Metabol. 2010 Dec;54(9):826-32
pubmed: 21340176
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Turk J Pediatr. 2015 May-Jun;57(3):277-81
pubmed: 26701948
J Clin Endocrinol Metab. 2005 May;90(5):2508-11
pubmed: 15713706
J Biol Chem. 2003 Dec 5;278(49):48563-9
pubmed: 14504283
Endocr Rev. 1991 Feb;12(1):91-108
pubmed: 2026124
Horm Res Paediatr. 2020;93(9-10):558-566
pubmed: 33780934
Curr Protein Pept Sci. 2017;18(5):515-521
pubmed: 28000554
Eur J Endocrinol. 2015 May;172(5):K19-25
pubmed: 25650406
J Clin Endocrinol Metab. 2012 Mar;97(3):E465-75
pubmed: 22170710
Lancet. 2004 Jun 26;363(9427):2128-35
pubmed: 15220035
Horm Res Paediatr. 2018;89(5):292-310
pubmed: 29874650
Nat Genet. 1997 Oct;17(2):201-5
pubmed: 9326943
Endocr Rev. 2011 Feb;32(1):81-151
pubmed: 21051590
J Clin Endocrinol Metab. 2002 Dec;87(12):5714-21
pubmed: 12466376
J Endocrinol Invest. 2021 Oct;44(10):2219-2226
pubmed: 33666875
J Clin Invest. 1966 Dec;45(12):1946-54
pubmed: 4288776
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22294-22299
pubmed: 31611378
Gynecol Endocrinol. 2013 Jan;29(1):10-5
pubmed: 22954317
J Biol Chem. 1989 Oct 25;264(30):18076-82
pubmed: 2808364
J Clin Endocrinol Metab. 2002 Aug;87(8):3682-90
pubmed: 12161496
J Clin Endocrinol Metab. 2008 Sep;93(9):3584-8
pubmed: 18559916
J Biol Chem. 1998 Feb 6;273(6):3158-65
pubmed: 9452426
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):71-78
pubmed: 26862015
Eur J Endocrinol. 2008 Mar;158(3):385-92
pubmed: 18299473
Endocr Connect. 2019 Feb;8(2):100-110
pubmed: 30668521
Endocrinol Metab Clin North Am. 1994 Jun;23(2):341-57
pubmed: 8070426
Endocr Rev. 2019 Dec 1;40(6):1605-1625
pubmed: 31294783
Clin Case Rep. 2015 Oct;3(10):793-7
pubmed: 26509008
J Clin Endocrinol Metab. 2005 Jul;90(7):4362-5
pubmed: 15811924
J Clin Res Pediatr Endocrinol. 2018 Mar 29;10(3):206-215
pubmed: 29595516
J Clin Endocrinol Metab. 2010 Mar;95(3):994-9
pubmed: 20080843

Auteurs

Min Sun (M)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Jonathan W Mueller (JW)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Lorna C Gilligan (LC)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Angela E Taylor (AE)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Fozia Shaheen (F)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Anna Noczyńska (A)

Department of Endocrinology and Diabetology for Children and Adolescents, Wroclaw Medical University, Wroclaw, Poland.

Guy T'Sjoen (G)

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.

Louise Denvir (L)

Department of Paediatric Endocrinology and Diabetes, Queen's Medical Centre, Nottingham, UK.

Savitha Shenoy (S)

Children's and Adolescent Services, University Hospitals of Leicester NHS Trust, Leicester, UK.

Piers Fulton (P)

West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Timothy D Cheetham (TD)

Newcastle University c/o Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.

Helena Gleeson (H)

Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Department of Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Mushtaqur Rahman (M)

Department of Endocrinology, Northwick Park Hospital, London Northwest University Healthcare NHS Trust, London, UK.

Nils P Krone (NP)

Academic Unit of Child Health, Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.

Norman F Taylor (NF)

Department of Clinical Biochemistry, King's College Hospital, London, UK.

Cedric H L Shackleton (CHL)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Benioff Children's Hospital, University of California San Francisco, Oakland, California, USA.

Wiebke Arlt (W)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Jan Idkowiak (J)

Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH